Veal GJ

Latest

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
Abstract 4651: Characterization of the clinical pharmacokinetics of actinomycin D and the influence of pharmacogenetic variation in children with cancer
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer
Population pharmacokinetic investigation of actinomycin-D in children and young adults
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma
Pharmacokinetics of high-dose cyclophosphamide and its metabolites in paediatric patients
Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapy
Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
Human renal function maturation: A quantitative description using weight and postmenstrual age
Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
Pharmacogenetics and metabolism of cyclophosphamidein paediatric cancer patients
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – A study of the United Kingdom Children's Cancer Study Group
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – A study of the United Kingdom Children′s Cancer Study Group
Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: How much do we really know?
A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer
Pharmacokinetics of dactinomycin in a pediatric patient population: A United Kingdom Children's Cancer Study Group Study
Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics